p53-MDM2-IN-1

CAS No. 381717-91-5

p53-MDM2-IN-1( —— )

Catalog No. M36397 CAS No. 381717-91-5

p53-MDM2-IN-1 (Example 30), an inhibitor of the p53-MDM2/X protein interaction, exhibits a K i value of 23.35 μM and holds potential for applications in anti-tumor research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 In Stock
5MG 466 In Stock
10MG 679 In Stock
25MG 1003 In Stock
50MG 1362 In Stock
100MG 1782 In Stock
500MG 3573 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    p53-MDM2-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    p53-MDM2-IN-1 (Example 30), an inhibitor of the p53-MDM2/X protein interaction, exhibits a K i value of 23.35 μM and holds potential for applications in anti-tumor research.
  • Description
    p53-MDM2-IN-1 (Example 30) is an inhibitor of p53-MDM2/X protein interaction with an Ki value of 23.35 μM. p53-MDM2-IN-1 can be used for anti-tumor research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    MDM2-p53
  • Recptor
    Mdm2 | p53
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    381717-91-5
  • Formula Weight
    421.88
  • Molecular Formula
    C23H20ClN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=O)(C=1C(N(CCCN2C=CN=C2)C(=O)C1O)C3=CC=C(Cl)C=C3)C4=CC=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhang W, et al. Pyrrylketone compound and application thereof as drug. China. CN102603717.
molnova catalog
related products
  • AQ-101

    AQ-101 is a novel small-molecule anthraquinone analog that induces MDM2 protein degradation (Kd=0.37 uM) through a self-ubiquitination and proteasome-mediated mechanism.

  • MS7972

    MS7972 is a small molecules that blocks p53 and CREB binding protein (CBP) association.

  • SP 141

    SP 141 is a MDM2 inhibitor.SP-141 promotes MDM2 auto-ubiquitination and degradation, with anticancer activity.SP141, which bound directly to MDM2, promoting its auto-ubiquitination and degradation by the proteasome.